Search filters

List of works by Robert Motzer

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

scientific article published on 01 January 2005

A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma

scientific article published on 10 June 2016

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

scientific article published in 2022

A brief symptom index for advanced renal cell carcinoma

scientific article

A case for the use of receiver operating characteristic analysis of potential clinical efficacy biomarkers in advanced renal cell carcinoma

scientific article

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response

scientific article published on 20 August 2020

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC).

scientific article

A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors.

scientific article published on 17 February 2013

A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma

scientific article published in November 2006

A postoperative prognostic nomogram for renal cell carcinoma

scientific article published in July 2001

A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.

scientific article published on 22 April 2011

ALLELIC LOSS ON CHROMOSOMES 8 AND 9 CORRELATES WITH CLINICAL OUTCOME IN LOCALLY ADVANCED CLEAR CELL CARCINOMA OF THE KIDNEY

scientific article published on 01 March 2002

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

scientific article

Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors

scientific article published on May 2007

Advances in Urologic Oncology: Results Progress From Successful Interdisciplinary Research

scientific article published on 01 December 2006

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network

scientific article

An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma

scientific article

Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth.

scientific article published on 17 February 2012

Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma.

scientific article published on 23 April 2014

Author Correction: Towards individualized therapy for metastatic renal cell carcinoma

scientific article published on 01 October 2019

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

scientific article published on 07 September 2020

Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis

scientific article

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

scientific article

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

scientific article

Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial

scientific article

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma.

scientific article published on 12 January 2012

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs.

scientific article published on 07 August 2015

Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma

scientific article published on 01 March 2022

Body Mass Index Is Associated With Higher Lymph Node Counts During Retroperitoneal Lymph Node Dissection ⬇️

scientific article published on December 14, 2011

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.

scientific article

Calvert's formula for dosing carboplatin: overview and concerns of applicability in high-dose setting

scientific article published in September 2000

Carbonic Anhydrase IX Expression in Clear Cell Renal Cell Carcinoma

scientific article published on 01 March 2008

Carcinoid tumor of the kidney

scientific article published on 01 April 2000

Cardiovascular events among 1090 cancer patients treated with sunitinib, interferon, or placebo: A comprehensive adjudicated database analysis demonstrating clinically meaningful reversibility of cardiac events

scientific article published on 12 June 2014

Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor

scientific article

Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma

scientific article

Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma

scientific article published on 21 June 2016

Chemotherapy for advanced germ cell tumors

scientific article published on December 2006

Chemotherapy for teratoma with malignant transformation

scientific article

Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma.

scientific article published on 23 February 2016

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

scientific article published on 2 July 2007

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.

scientific article

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

scientific article published on 08 February 2014

Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors.

scientific article

Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma

scientific article published on 27 September 2012

Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma

scientific article published on 17 December 2010

Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer

scientific article published in January 2012

Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour

scientific article published on 01 May 2007

Clinical practice guidelines for the treatment of metastatic renal cell carcinoma: today and tomorrow.

scientific article published on January 2011

Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor

scientific article published in July 2003

Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors

scientific article published in September 2005

Combination therapy for advanced and metastatic kidney cancer

scientific article published on 01 February 2019

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

scientific article

Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression

scientific article published on 27 March 2020

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

scientific article

Continuing a cancer treatment despite tumor growth may be valuable: sunitinib in renal cell carcinoma as example

scientific article

Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial

scientific article published on 23 December 2014

Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225

scientific article published on 01 June 2001

Cytokine therapy in renal cell cancer

scientific article published on 01 November 2000

Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer.

scientific article

DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy

scientific article published on 01 June 2020

Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with Pazopanib

scientific article published on 17 June 2015

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

scientific article published on 17 February 2014

Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this “adaptive response” in mice

scientific article published on 01 June 1999

Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial

scientific article

Economic evaluation of sunitinib malate for the first-line treatment of metastatic renal cell carcinoma

scientific article published in August 2008

Editorial: Predicting Necrosis After Chemotherapy for Advanced Nonseminomatous Germ Cell Tumor—Surrogate End Points, Decreasing Morbidity and Patient Outcome

scientific article published on 01 May 2004

Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma

scientific article published on 01 January 2004

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

scientific article published on 01 September 2020

Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.

scientific article

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma

scientific article

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

scientific article (publication date: 9 August 2008)

Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors

scientific article published in December 2005

Evaluation of lymph node counts in primary retroperitoneal lymph node dissection.

scientific article

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

scientific article published on 22 March 2012

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.

scientific article

Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial

scientific article published on 25 September 2020

Expression of T-cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma

scientific article published on 20 November 2020

Expression of prostate-specific membrane antigen in renal cortical tumors.

scientific article published on 14 March 2008

Fatigue in patients with advanced renal cell carcinoma receiving sunitinib on an intermittent versus continuous dosing schedule in a randomized phase II trial.

scientific article

Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinib.

scientific article published on 4 February 2013

Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach.

scientific article published on June 2015

From molecular understanding to clinical advances

scientific article published on 24 December 2013

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

scientific article published on 4 January 2018

Genomic deregulation during metastasis of renal cell carcinoma implements a myofibroblast-like program of gene expression.

scientific article

Good-risk-advanced germ cell tumors: historical perspective and current standards of care.

scientific article published on 10 June 2009

Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-alpha in a phase III trial: final results and geographical analysis

scientific article

High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

publication published on 26 May 2021

High-dose chemotherapy and stem cell transplantation for advanced testicular cancer

scientific article published on July 2011

Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms.

scientific article published on 9 October 2013

Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial

scientific article

Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib

scientific article

ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease

scientific article published on 24 June 2011

IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma

scientific article

Immune Checkpoint Therapy in Renal Cell Carcinoma.

scientific article published on March 2016

Immunohistochemical Expression of Hypoxia Inducible Factor-1α and its Downstream Molecules in Sarcomatoid Renal Cell Carcinoma

scientific article published on 01 April 2007

Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma

scientific article

Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell Tumors

article

Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trials

scientific article

Incidence and Clinical Outcome of Patients with Teratoma in the Retroperitoneum Following Primary Retroperitoneal Lymph Node Dissection for Clinical Stages I and IIA Nonseminomatous Germ Cell Tumors

scientific article published on 01 October 2003

Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma.

scientific article published on 11 June 2012

Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.

scientific article published on March 2007

Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy

scientific article

Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

scientific article published on October 2007

Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma

scientific article published on 23 December 2015

Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors

scientific article published in May 2008

Innovations and challenges in renal cancer: consensus statement from the first international conference

scientific article published in September 2004

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

scientific article published in January 2002

Interferon-α Resistance Associated Genes in Renal Cell Carcinoma Identified by Expression Profiling

article

Intra- and interobserver variability in CT measurements in oncology

scientific article published on 03 July 2013

Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma

scientific article

Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?

scientific article published on 11 December 2007

Kidney cancer, version 2.2014.

scientific article

Kidney cancer, version 3.2015.

scientific article published on February 2015

Kidney cancer. Clinical practice guidelines.

scientific article

Late relapse of testicular germ cell tumors

scientific article

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

scientific article published on 22 October 2015

Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma ⬇️

scientific article published on May 24, 2013

Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma

scientific article published on 29 January 2007

Long-term follow-up of bilateral sporadic renal tumors

scientific article published in May 2003

Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib.

scientific article published on 10 August 2010

Long-term response with sunitinib for metastatic renal cell carcinoma

scientific article

Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience

scientific article published on 15 December 2014

Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse

scientific article published on 01 April 2001

Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.

scientific article published on 08 April 2011

Management of recurrence and follow-up strategies for patients with seminoma and selected high-risk groups

scientific article published on November 2003

Medical treatment of advanced testicular cancer.

scientific article

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy.

scientific article published on 11 January 2016

NCCN clinical practice guidelines in oncology: kidney cancer

article

NCCN clinical practice guidelines in oncology: testicular cancer

article

Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression

scientific article

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-Free Survival in Post-Nephrectomy High-Risk Loco-Regional RCC: Analysis of the S-TRAC Trial

scientific article published on 16 June 2020

New Perspectives on the Treatment of Metastatic Renal Cell Carcinoma: An Introduction and Historical Overview ⬇️

scientific article published on January 1, 2011

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial

scientific article published on December 2014

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

scientific article published on 25 September 2015

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial

scientific article published on 16 July 2020

Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma

scientific article published on March 2010

Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

scientific article published on 01 December 2007

Novel approaches targeting the vascular endothelial growth factor axis in renal cell carcinoma

scientific article published on July 2013

Outcomes After Resection of Postchemotherapy Residual Neck Mass in Patients With Germ Cell Tumors—An Update

scientific article published on 01 March 2011

Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.

scientific article published on 23 March 2012

Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover--The Case of Pazopanib in Advanced Renal Cell Carcinoma.

scientific article

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

scientific article (publication date: August 2009)

Overall survival in renal-cell carcinoma with pazopanib versus sunitinib

scientific article published on 01 May 2014

PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN

scientific article published on 01 August 2019

PTEN Expression, Not Mutation Status for , or , Correlates With Outcome on Everolimus in Patients With Renal Cell Carcinoma Treated on RECORD-3

scientific article published on 16 October 2018

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

scientific article published on 01 January 2007

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors

scientific article published on 16 May 2016

Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer

scientific article published on 01 June 2000

Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome

scientific article

Partial nephrectomy: the rationale for expanding the indications

scientific article published in August 2002

Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial

scientific article published on 11 April 2013

Patient-reported outcomes from the phase 3 randomized IMmotion151 trial: atezolizumab + bevacizumab vs sunitinib in treatment-naive metastatic renal cell carcinoma

scientific article published on 03 March 2020

Patient-reported outcomes in a phase iii study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy

scientific article published on April 2011

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

scientific article

Pazopanib versus sunitinib in renal cancer

scientific article

Perspective: What next for treatment?

scientific article published on 14 September 2016

Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma ⬇️

scientific article published on September 6, 2011

Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas

scientific article published on 30 May 2018

Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer

scientific article published on 01 August 2004

Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma

scientific article

Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.

scientific article published on 17 February 2009

Phase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma

scientific article

Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors.

scientific article published on 16 May 2015

Phase I/II Trial of Temsirolimus Combined With Interferon Alfa for Advanced Renal Cell Carcinoma

scientific article published on 01 September 2007

Phase I/II trial of sunitinib plus gefitinib in patients with metastatic renal cell carcinoma

scientific article published in December 2010

Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors

scientific article published on 23 May 2007

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma

scientific article published on 21 July 2014

Phase II trial of ZD1839 (IRESSA) in patients with advanced renal cell carcinoma

scientific article published in August 2003

Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma

scientific article

Phase II trial of bortezomib for patients with advanced renal cell carcinoma

scientific article published in September 2004

Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma

scientific article published in November 2002

Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma

scientific article published in January 2001

Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma

scientific article published on 27 December 2007

Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma

scientific article published in March 2008

Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors

scientific article published on 01 August 2000

Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4)

scientific article published on 17 December 2015

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.

scientific article published on 23 June 2009

Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors

scientific article

Phase II trial of thalidomide for patients with advanced renal cell carcinoma

scientific article published in January 2002

Phase III Trial of Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

scientific article published on 06 November 2018

Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors

scientific article published in January 2007

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma

scientific article published in August 2000

Poor-risk testicular cancer and high-dose chemotherapy

scientific article published on 20 October 2003

Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor

scientific article

Predicting Teratoma in the Retroperitoneum in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection

article

Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy

scientific article published in May 2001

Predicting survival of patients with metastatic renal cell carcinoma

scientific article published in September 2004

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

scientific article published on 14 July 2021

Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor-Targeted Therapy for Renal Cell Carcinoma.

scientific article published on 31 October 2015

Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma

scientific article

Prognostic factors for metastatic kidney cancer.

scientific article published on January 2003

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

scientific article

Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma ⬇️

scientific article published on May 21, 2013

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

scientific article

Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experience.

scientific article published in September 2004

Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group

scientific article

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

scientific article

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.

scientific article published on 26 July 2011

Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α ⬇️

scientific article published on May 8, 2012

Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial

scientific article

Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial

scientific article published in August 2008

Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa

scientific article published on March 2009

Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma

scientific article published on 27 January 2016

RETROPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH LOW STAGE TESTICULAR CANCER WITH EMBRYONAL CARCINOMA PREDOMINANCE AND/OR LYMPHOVASCULAR INVASION

scientific article published on 01 August 2005

Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations

scientific article

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma ⬇️

scientific article

Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma

article

Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma

scientific article published in April 2001

Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma.

scientific article

Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

scientific article

Re: Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

scientific article published on 12 June 2007

Recommendations of follow-up after treatment of germ cell tumors

scientific article

Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy

scientific article published in February 2004

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.

scientific article published on 05 December 2009

Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence

scientific article published on 01 July 2006

Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival

scientific article published on 01 May 2006

Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours

scientific article published on 23 March 2016

Renal cell carcinoma: a priority malignancy for development and study of novel therapies.

scientific article

Renal cell carcinoma: progress against an elusive tumor

scientific article published on 01 April 2000

Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome

scientific article published on 01 October 2003

Research and innovation in the development of everolimus for oncology.

scientific article published on 17 February 2011

Resection of Primary Mediastinal Non-Seminomatous Germ Cell Tumors: A 28-Year Experience at Memorial Sloan-Kettering Cancer Center

scientific article published on 01 July 2011

Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials

scientific article published in October 2003

Results of Retroperitoneal Lymph Node Dissection for Clinical Stage I and II Pure Embryonal Carcinoma of the Testis

scientific article published on 01 October 2003

Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome

scientific article published on 01 April 2005

Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma

scientific article published on 17 July 2008

Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum

scientific article published on 01 February 2001

Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma.

scientific article published on 7 April 2016

Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis

scientific article published on 8 June 2014

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial.

scientific article published on 22 May 2018

Salvage chemotherapy for patients with advanced pure seminoma

scientific article published in January 2002

Sarcomatoid renal cell carcinoma: biology, natural history and management

scientific article published on 13 October 2020

Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.

scientific article published on October 2011

Sequelae of treatment in long-term survivors of testis cancer

scientific article published on 12 June 2011

Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.

scientific article published on March 2000

Stage I testicular cancer management and necessity for surgical expertise

scientific article published on 5 May 2008

Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation

scientific article published in January 2010

Sunitinib Does Not Accelerate Tumor Growth in Patients with Metastatic Renal Cell Carcinoma

scientific article published on 07 February 2013

Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinoma.

scientific article

Sunitinib efficacy against advanced renal cell carcinoma

scientific article published on 17 September 2007

Sunitinib in patients with metastatic renal cell carcinoma

scientific article

Sunitinib malate for the treatment of solid tumours: a review of current clinical data

scientific article

Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials

scientific article published on 16 September 2013

Sunitinib therapy in renal cell carcinoma

scientific article published on 18 February 2008

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

scientific article

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

scientific article

Survival Prediction in Everolimus-treated Patients with Metastatic Renal Cell Carcinoma Incorporating Tumor Burden Response in the RECORD-1 Trial ⬇️

scientific article published on November 21, 2012

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

scientific article

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

scientific article published on 01 July 2020

Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC).

scientific article published on 03 May 2012

Systemic therapy for metastatic renal cell carcinoma.

scientific article

Systemic treatment options for untreated patients with metastatic clear cell renal cancer.

scientific article published on August 2013

Targeted drugs for metastatic renal cell carcinoma

scientific article published in December 2007

Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies

scientific article published on 06 October 2008

Targeted therapy for metastatic renal cell carcinoma

scientific article

Targeted therapy for metastatic renal cell carcinoma

scientific article published on 01 March 2006

Targeting renal cell carcinoma.

scientific article

Targeting von Hippel-Lindau pathway in renal cell carcinoma

scientific article published on December 2006

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

scientific article (publication date: 31 May 2007)

Ten years of progress in renal cell carcinoma

article

Testicular Cancer, Version 2.2015

scientific article published in June 2015

Testicular Seminoma: A Clinicopathologic and Immunohistochemical Study of 105 Cases with Special Reference to Seminomas with Atypical Features

scientific article published on 01 January 2002

Testicular cancer

scientific article published on 01 April 2012

Testicular cancer. Clinical practice guidelines.

scientific article

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma

scientific article published on 10 May 2018

The Right Drug for the Right Patient: Navigating Systemic Therapy Options in Metastatic Renal Cell Carcinoma and Future Directions.

scientific article published on October 2015

The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiers

scientific article published in February 2004

The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling

scientific article published on 14 August 2014

The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy

scientific article published on 29 August 2019

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor

scientific article published on 01 February 2008

The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours

scientific article published on 01 April 2003

Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development

scientific article

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma

scientific article published on October 2006

Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial

scientific article published on 09 September 2013

Towards individualized therapy for metastatic renal cell carcinoma

scientific article published on 01 October 2019

Transcriptional program associated with IFN-alpha response of renal cell carcinoma.

scientific article published on March 2006

Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial

scientific article published on 08 January 2019

Treatment of Advanced Renal-Cell Carcinoma

scientific article published on 01 March 2016

Treatment options in renal cell carcinoma: past, present and future

scientific article published on September 2007

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology

scientific article

Treatment outcome for metastatic papillary renal cell carcinoma patients

scientific article published on December 2006

Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies.

scientific article

Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma

scientific article

Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy

scientific article

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

scientific article published on 14 January 2019

Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a

scientific article published on 01 July 1999

Using the Rasch model to validate and enhance the interpretation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index--Disease-Related Symptoms scale

scientific article published on 11 November 2008

Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

scientific article published on 27 October 2015

Weighing Risks and Benefits of Postchemotherapy Retroperitoneal Lymph Node Dissection: Not So Easy

scientific article published on 21 December 2009

mTOR inhibitors in advanced renal cell carcinoma

scientific article

Paulina is supported by:

About Paulina

Help